Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ocata Therapeutics Inc (NASDAQ:OCAT)

8.46
Delayed Data
As of Feb 05
 -0.01 / -0.12%
Today’s Change
3.06
Today|||52-Week Range
8.71
+0.48%
Year-to-Date
No recent news for Ocata Therapeutics Inc.

Today’s Trading

Previous close8.47
Today’s open8.46
Day’s range8.45 - 8.47
Volume395,966
Average volume (3 months)756,832
Market cap$357.9M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-17.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-29.83%
P/E ratioNM
Price/Sales1,206.25
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TLGTTeligent Inc-0.36-5.09%
CORTCorcept Therapeutics...-0.16-4.51%
VNDAVanda Pharmaceutical...-0.17-1.93%
FLMLFlamel Technologies ...-0.16-1.68%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateFebruary 25, 2016
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$157.9K
Annual profit (last year)-$34.7M
Net profit margin-22,010.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paul K. Wotton
Chief Operating &
Financial Officer
Edward H. Myles
Corporate headquarters
Marlborough, Massachusetts

Forecasts

Partner Offers